Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
35 hedge funds and large institutions have $103M invested in Ocean Biomedical, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
3% more funds holding
Funds holding: 34 → 35 (+1)
4% more capital invested
Capital invested by funds: $99.4M → $103M (+$3.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$5.75M |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$4.04M |
| 3 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
+$811K |
| 4 |
D.E. Shaw & Co
New York
|
+$755K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$406K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$6.79M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$1.04M |
| 3 |
MSU
Mizuho Securities USA
New York
|
-$744K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$26.4K |
| 5 |
Walleye Capital
New York
|
-$2.02K |
OCEA Hedge Fund Activity: Q2 2022 in Review
35 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q2 2022, worth a combined $103M — up 3.5% from $99.4M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OCEA positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was First Trust Capital Management, opening a new position worth an estimated $5.75M. The largest seller was Beryl Capital Management, exiting entirely with an estimated $6.79M sold.
- 35 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q2 2022, up from 34 in Q1 2022.
- Funds reported $103M of Ocean Biomedical, Inc. Common Stock stock for Q2 2022, up 3.5% quarter-over-quarter.
- 4 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q2 2022 and 3 closed out, a net change of +1 holder.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q2 2022 was First Trust Capital Management, an estimated $5.75M added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q2 2022 was Beryl Capital Management, an estimated $6.79M sold.
Based on aggregated 13F filings for Q2 2022.